Compound Development Leader
Current
2021 - Present
~5 yrs 6 mos
AeroLeads people directory · profile
Kathryn Packman Email & Phone Number
Global Compound Development Leader Johnson&Johnson Innovative Medicine
at
The Janssen Pharmaceutical Companies of Johnson & Johnson
3 work emails found
@janssen.com
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Global Compound Development Leader Johnson&Johnson Innovative Medicine
Location
Newton Highlands, Massachusetts, United States
Who is Kathryn Packman? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kathryn Packman is listed as Global Compound Development Leader Johnson&Johnson Innovative Medicine at The Janssen Pharmaceutical Companies of Johnson & Johnson, based in Newton Highlands, Massachusetts, United States. AeroLeads shows a work email signal at janssen.com and a matched LinkedIn profile for Kathryn Packman.
Kathryn Packman previously worked as Compound Development Leader at The Janssen Pharmaceutical Companies Of Johnson & Johnson and Global Head of Tumor Biology at The Janssen Pharmaceutical Companies Of Johnson & Johnson. Kathryn Packman holds Phd, Cell And Molecular Biology from University Of Notre Dame.
Company email context
Email format at The Janssen Pharmaceutical Companies of Johnson & Johnson
This section adds company-level context without repeating Kathryn Packman's masked contact details.
{first_initial}{last}@janssen.com
92% confidence
AeroLeads found 3 current-domain work email signals for Kathryn Packman. Compare company email patterns before reaching out.
Profile bio
About Kathryn Packman
Clinical and Preclinical Oncology Research and Development Leader with >20 years' drug discovery and pharmacology experience. Proven track record in leading tumor biology research teams delivering >30 drugs to clinic. Oncology leadership with responsibility for research project portfolio strategy and prioritization. Broad knowledge in small and large molecule drug development. Brought cutting-edge technologies to support preclinical data packages.
Listed skills include Cancer Research, In Vivo Pharmacology, Drug Discovery, Biomarkers, and 9 others.
Current workplace
Kathryn Packman's current company
Company context helps verify the profile and gives searchers a useful next step.
The Janssen Pharmaceutical Companies Of Johnson & Johnson
AeroLeads page
8 roles · 27 years
Kathryn Packman work experience
A career timeline built from the work history available for this profile.
Global Head Of Tumor Biology
Sep 2015 - Jun 2023
Scientific Director Oncology Collaborations
Oct 2013 - Aug 2015
Industry Advisory Board Member
Current
2017 - Present
~9 yrs 6 mos
Head Of Preclinical Oncology Research
Appointed to define strategies and deliver preclinical research support to the Global Oncology R&D head, head of Translational Medicine, and USA head of Academic Alliances. • Ensure strategic alignment between research and exploratory development • Initiate, maintain and optimize preclinical collaborations with academic and biotech partners • Evaluate therapeutic and technology opportunities for partnering, academic alliances, and venture capital • Represent Roche in academic collaborations on Joint Research Committees with leading academic cancer research centers• Lead platform-based biology efforts for added value to global oncology programs• Responsible for preclinical research study design and implementation, data evaluation, reporting and regulatory documentation • Represent the Oncology Disease Therapeutic Area (Oncology DTA) on the TCRC Leadership Team• Represent the TCRC site on the Global DTA Oncology Management Team
Oct 2012 - Sep 2013
Head Of Tumor Biology/ In Vivo Pharmacology
Led 12 scientists (3 Ph.D.) in preclinical in vivo pharmacology research in support of all Oncology projects, including small molecules, biologics, RNAi, and peptides.• Oversaw development of rodent models of cancer including subcutaneous and orthotopic xenografts from established solid or hematological cell lines, patient-derived xenografts, allografts, experimental metastasis and genetically engineered models, bioluminescence and fluorescence imaging• Led team for pharmacokinetic, antitumor efficacy and biomarker studies to support all site oncology projects• Contributed key data for the development of 10 clinical candidates • Contributed towards preclinical modeling of dose-dense regimen for capecitabine under clinical investigation for metastatic breast cancer• Project Leader for RO5486055, a humanized Hepsin neutralizing antibody for treatment of prostate and breast cancer reaching Clinical Lead stage • Member of Roche Global and Nutley Site Discovery Oncology Leadership Teams• Core member of Target Identification team with significant input into strategy and target selection• Contributed guidance and decision-making to Oncology portfolio, in-licensing opportunities (therapeutics or technologies) and department staffing• Represented preclinical tumor biology on early clinical development teams• Member of joint project teams with external partners• Initiated and managed academic collaborations and contract research• Managed internal and outsourcing budget for in vivo pharmacology studies and technology licensing • Authored and amended animal research protocols to support preclinical oncology research studies• 9 year member of Institutional Animal Care and Use Committee (Chair for 3 yrs)• Member of Roche Global Ethics Committee, with remit to review and approve all non-human primate studies
Apr 2002 - Oct 2012
Adjunct Professor
2003 - 2013
~10 yrs
Postdoctoral Fellow
2000 - 2002
~2 yrs
2 education records
Kathryn Packman education
Phd, Cell And Molecular Biology
University Of Notre Dame
Bs, Biology
Suny Geneseo
FAQ
Frequently asked questions about Kathryn Packman
Quick answers generated from the profile data available on this page.
What company does Kathryn Packman work for?
Kathryn Packman works for The Janssen Pharmaceutical Companies of Johnson & Johnson.
What is Kathryn Packman's role at The Janssen Pharmaceutical Companies of Johnson & Johnson?
Kathryn Packman is listed as Global Compound Development Leader Johnson&Johnson Innovative Medicine at The Janssen Pharmaceutical Companies of Johnson & Johnson.
What is Kathryn Packman's email address?
AeroLeads has found 3 work email signals at @janssen.com for Kathryn Packman at The Janssen Pharmaceutical Companies of Johnson & Johnson.
Where is Kathryn Packman based?
Kathryn Packman is based in Newton Highlands, Massachusetts, United States while working with The Janssen Pharmaceutical Companies of Johnson & Johnson.
What companies has Kathryn Packman worked for?
Kathryn Packman has worked for The Janssen Pharmaceutical Companies Of Johnson & Johnson, Harper Cancer Research Institute, Roche Translational Clinical Research Center, Inc., Rutgers University, and University Of Notre Dame.
How can I contact Kathryn Packman?
You can use AeroLeads to view verified contact signals for Kathryn Packman at The Janssen Pharmaceutical Companies of Johnson & Johnson, including work email, phone, and LinkedIn data when available.
What schools did Kathryn Packman attend?
Kathryn Packman holds Phd, Cell And Molecular Biology from University Of Notre Dame.
What skills is Kathryn Packman known for?
Kathryn Packman is listed with skills including Cancer Research, In Vivo Pharmacology, Drug Discovery, Biomarkers, Oncology, Translational Research, Cell Biology, and Target Identification.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial